284 related articles for article (PubMed ID: 15358986)
1. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
2. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
Taraska T; Finnegan KT
J Pharmacol Exp Ther; 1997 Feb; 280(2):941-7. PubMed ID: 9023310
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').
O'Shea E; Granados R; Esteban B; Colado MI; Green AR
Neuropharmacology; 1998 Jul; 37(7):919-26. PubMed ID: 9776387
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
6. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
Colado MI; Green AR
Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
[TBL] [Abstract][Full Text] [Related]
7. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
Ricaurte GA; Martello AL; Katz JL; Martello MB
J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
Commins DL; Vosmer G; Virus RM; Woolverton WL; Schuster CR; Seiden LS
J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295
[TBL] [Abstract][Full Text] [Related]
9. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
[TBL] [Abstract][Full Text] [Related]
10. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.
Malberg JE; Seiden LS
J Neurosci; 1998 Jul; 18(13):5086-94. PubMed ID: 9634574
[TBL] [Abstract][Full Text] [Related]
11. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
12. 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
Schmidt CJ; Taylor VL; Abbate GM; Nieduzak TR
J Pharmacol Exp Ther; 1991 Jan; 256(1):230-5. PubMed ID: 1899117
[TBL] [Abstract][Full Text] [Related]
13. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
14. Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine.
Broening HW; Bacon L; Slikker W
J Pharmacol Exp Ther; 1994 Oct; 271(1):285-93. PubMed ID: 7965726
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
Colado MI; O'Shea E; Granados R; Murray TK; Green AR
Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
[TBL] [Abstract][Full Text] [Related]
16. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations.
Sabol KE; Lew R; Richards JB; Vosmer GL; Seiden LS
J Pharmacol Exp Ther; 1996 Feb; 276(2):846-54. PubMed ID: 8632358
[TBL] [Abstract][Full Text] [Related]
17. Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice.
Cadet JL; Ladenheim B; Hirata H; Rothman RB; Ali S; Carlson E; Epstein C; Moran TH
Synapse; 1995 Oct; 21(2):169-76. PubMed ID: 8584978
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM
Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
McCann UD; Yuan J; Ricaurte GA
Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
[TBL] [Abstract][Full Text] [Related]
20. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
Schmidt CJ; Abbate GM; Black CK; Taylor VL
J Pharmacol Exp Ther; 1990 Nov; 255(2):478-83. PubMed ID: 1978728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]